scholarly journals Correction: Almashaqbeh, O., et al., Removal of Selected Pharmaceuticals and Personal Care Products in Wastewater Treatment Plant in Jordan. Water 2019, 11, 2004

Water ◽  
2020 ◽  
Vol 12 (4) ◽  
pp. 1122
Author(s):  
Othman Al-Mashaqbeh ◽  
Diya Alsafadi ◽  
Sahar Dalahmeh ◽  
Shannon Bartelt-Hunt ◽  
Daniel Snow
Keyword(s):  
Wastewater Treatment ◽  
Wastewater Treatment Plant ◽  
Personal Care Products ◽  
Treatment Plant ◽  
Personal Care

The authors wish to make the following corrections to this paper [...]

scholarly journals Removal of Selected Pharmaceuticals and Personal Care Products in Wastewater Treatment Plant in Jordan

Water ◽  
2019 ◽  
Vol 11 (10) ◽  
pp. 2004 ◽  
Author(s):  
Al-Mashaqbeh ◽  
Alsafadi ◽  
Dalahmeh ◽  
Bartelt-Hunt ◽  
Snow
Keyword(s):  
Mass Spectrometry ◽  
Wastewater Treatment ◽  
Removal Efficiency ◽  
Wastewater Treatment Plant ◽  
Personal Care Products ◽  
Treatment Plant ◽  
Treated Wastewater ◽  
Tandem Mass ◽  
Personal Care ◽  
Raw Wastewater

The largest wastewater treatment plant in Jordan was monitored in the summer to determine the removal of pharmaceuticals and personal care products (PPCPs). Grab samples were collected from the influent and effluent of As-Samra Wastewater Treatment Plant (WWTP). Liquid chromatography and tandem mass spectrometry (LC–MS/MS) were utilized to determine the concentrations of 18 compounds of pharmaceuticals and personal care products (PPCPs). The results showed that 14 compounds were detected in the collected samples from the influent and effluent of As-Samra WWTP. These compounds are 1,7-dimethylxanthine, amphetamine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine, diphenhydramine, methylenedioxymethamphetamine (MDMA), morphine, phenazone, sulfamethazine, sulfamethoxazole, thiabendazole, and trimethoprim. However, four compounds were below the detection limit (<0.005 µg/L), namely cimetidine, methylenedioxyamphetamine (MDA), methamphetamine, and sulfachloropyridazine. Among PPCPs, the highest estimated average concentrations in raw wastewater were caffeine, acetaminophen, 1,7-dimethylxanthine, cotinine, and carbamazepine sampled during the summer, at an estimated concentration of 155.6 µg/L, 36.7 µg/L, 10.49 µg/L, and 1.104 µg/L, respectively. However, the highest estimated average concentrations in treated wastewater were for carbamazepine, sulfamethoxazole, caffeine, cotinine, and acetaminophen, at 0.856 µg/L, 0.096 µg/L, 0.086 µg/L, 0.078 µg/L, and 0.041 µg/L, respectively. In general, the results showed that some compounds in the collected samples of wastewater in Jordan have concentrations exceeding the values reported in the literature. The removal efficiency rates of 1,7-dimethylxanthine, acetaminophen, caffeine, cotinine, morphine, and trimethoprim were higher than 95%, while those of carbamazepine, sulfamethazine, and sulfamethoxazole were lower than 22.5%. Moreover, diphenhydramine and thiabendazole had negative removal efficiency rates. The removal efficiency rates of the PPCPs in As-Samra WWTP were generally consistent with those of indicator compounds reported in the literature for conventional WWTPs.

Removal of pharmaceuticals and personal care products in a membrane bioreactor wastewater treatment plant

2014 ◽  
Vol 69 (11) ◽  
pp. 2221-2229 ◽  
Author(s):  
M. Kim ◽  
P. Guerra ◽  
A. Shah ◽  
M. Parsa ◽  
M. Alaee ◽  
...  
Keyword(s):  
Wastewater Treatment ◽  
Wastewater Treatment Plant ◽  
Membrane Bioreactor ◽  
Personal Care Products ◽  
Treatment Plant ◽  
Dry Weight ◽  
Personal Care ◽  
High Concentrations ◽  
Final Effluent

Ninety-nine pharmaceuticals and personal care products (PPCPs) were analyzed in influent, final effluent, and biosolids samples from a wastewater treatment plant employing a membrane bioreactor (MBR). High concentrations in influent were found for acetaminophen, caffeine, metformin, 2-hydroxy-ibuprofen, paraxanthine, ibuprofen, and naproxen (104–105 ng/L). Final effluents contained clarithromycin, metformin, atenolol, carbamazepine, and trimethoprim (&gt;500 ng/L) at the highest concentrations, while triclosan, ciprofloxacin, norfloxacin, triclocarban, metformin, caffeine, ofloxacin, and paraxanthine were found at high concentrations in biosolids (&gt;103 ng/g dry weight). PPCP removals varied from −34% to &gt;99% and 23 PPCPs had ≥90% removal. Of the studied PPCPs, 26 compounds have been rarely or never studied in previous membrane bioreactor (MBR) investigations. The removal pathway showed that acetaminophen, 2-hydroxy-ibuprofen, naproxen, ibuprofen, codeine, metformin, enalapril, atorvastatin, caffeine, paraxanthine, and cotinine exhibited high degradation/transformation. PPCPs showing strong sorption to solids included triclocarban, triclosan, miconazole, tetracycline, 4-epitetracycline, norfloxacin, ciprofloxacin, doxycycline, paroxetine, and ofloxacin. Trimethoprim, oxycodone, clarithromycin, thiabendazole, hydrochlorothiazide, erythromycin-H2O, carbamazepine, meprobamate, and propranolol were not removed during treatment, and clarithromycin was even formed during treatment. This investigation extended our understanding of the occurrence and fate of PPCPs in an MBR process through the analysis of the largest number of compounds in an MBR study to date.

Sign in / Sign up

Export Citation Format

Share Document